ClassID:

169331

G01N33/6893 - page 12 - CPC Classification

Classification description:

Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Recent Application in this class:
#3301
20150337051
2015-11-26

TEM-1 diagnostic antibodies

#3302
20150337033
2015-11-26

Humanized or affinity-matured anti Ang-2 antibody and uses thereof

#3303
20150330997
2015-11-19

Type 2 diabetes biomarkers and uses thereof

#3304
20150328338
2015-11-19

Chemical model of a neurodegenerative disease, method for preparation and uses of same

#3305
20150323554
2015-11-12

Analysis of a panel of cerebrotendinous xanthomatosis biomarkers using site specific derivation and LC/MS/MS workflow

#3306
20150323553
2015-11-12

Methods for the prevention or treatment of scoliosis

#3307
20150323552
2015-11-12

Methods and devices for rapid assessment of severity of injury

#3308
20150323551
2015-11-12

Biomarkers for liver fibrosis

#3309
20150323550
2015-11-12

METHOD FOR THE DIAGNOSIS OF SYSTEMIC SCLERODERMA OR OF PULMONARY ARTERIAL HYPERTENSION

#3310
20150323546
2015-11-12

Biomarkers in inflammatory bowel disease

#3311
20150323526
2015-11-12

Immunochromatography devices, methods, and kits

#3312
20150322520
2015-11-12

Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis

#3313
20150322514
2015-11-12

Diagnostic markers for platelet function and methods of use

#3314
20150320825
2015-11-12

Saposin-A derived peptides and uses thereof

#3315
20150316563
2015-11-05

Method for the diagnosis of metachromatic leukodystrophy

#3316
20150315650
2015-11-05

CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same

#3317
20150313976
2015-11-05

Prion epitopes and methods of use thereof

#3318
20150309052
2015-10-29

ACUTE KIDNEY INJURY

#3319
20150309051
2015-10-29

Isovalerylglycine as biomarker for the predispositon for weight gain and obesity

#3320
20150309050
2015-10-29

Diagnostic and therapeutic methods and products related to anxiety disorders

#3321
20150309022
2015-10-29

Synthetic ligands for the differentiation of closely related toxins and pathogens

#3322
20150307611
2015-10-29

Methods for diagnosing and treating inflammatory bowel disease

#3323
20150306195
2015-10-29

Hemoglobin receptor as novel vaccine for leishmaniasis

#3324
20150306190
2015-10-29

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

#3325
20150301070
2015-10-22

Lipid biomarkers for stable and unstable heart disease

#3326
20150301067
2015-10-22

METHODS AND ASSAYS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

#3327
20150301066
2015-10-22

Biomarkers for the identification of liver damage

#3328
20150301022
2015-10-22

Methods for determining the risk of acute graft versus host disease

#3329
20150299301
2015-10-22

Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor

#3330
20150297591
2015-10-22

METHODS OF TREATING PULMONARY FIBROSIS

#3331
20150293131
2015-10-15

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS

#3332
20150293124
2015-10-15

Method to determine treatment of acute heart failure

#3333
20150293123
2015-10-15

Cathelicidin as novel inflammatory bowel disease marker and therapy for colitis associated intestinal fibrosis

#3334
20150293122
2015-10-15

USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE

#3335
20150293121
2015-10-15

Method for testing for cardiovascular disease with cyclophilin A

#3336
20150293120
2015-10-15

MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS

#3337
20150293119
2015-10-15

ASSESSING RENAL STRUCTURAL ALTERATIONS AND OUTCOMES

#3338
20150293088
2015-10-15

Signal amplification in lateral flow and related immunoassays

#3339
20150291963
2015-10-15

Sortilin 1 is a novel inducer of vascular calcification

#3340
20150290286
2015-10-15

Pharmaceutical composition for use in the treatment of dysfunction associated with aging

#3341
20150285824
2015-10-08

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

#3342
20150285823
2015-10-08

COMPOSITIONS AND METHODS RELATED TO DORMANT SENESCENCE-PRONE CELLS (DSPC)

#3343
20150285822
2015-10-08

Therapeutic and diagnostic methods and compositions for neurodegenerative diseases

#3344
20150285821
2015-10-08

Marker peptide for determining risk of hyperglycemia and use thereof

#3345
20150285800
2015-10-08

Non-invasive biomarker to identify subject at risk of preterm delivery

#3346
20150285787
2015-10-08

METHOD FOR IDENTIFYING MOLECULAR MARKERS OF CHILDREN'S SKIN

#3347
20150276765
2015-10-01

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

#3348
20150276764
2015-10-01

DETERMINING DISEASE STATES USING BIOMARKER PROFILES

#3349
20150276763
2015-10-01

BIOMARKERS FOR THE PROGNOSIS OF ISCHEMIC STROKE

#3350
20150276762
2015-10-01

Collagen-derived recombinant proteins with von Willebrand factor-binding activity

#3351
20150276718
2015-10-01

Therapeutic or prophylactic agent for retinopathy of prematurity, testing method for retinopathy of prematurity, and screening method for therapeutic or prophylactic substance for retinopathy of prematurity

#3352
20150274838
2015-10-01

Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

#3353
20150274764
2015-10-01

Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis

#3354
20150273083
2015-10-01

Methods for the diagnosis and treatment of sjögren's syndrome

#3355
20150268253
2015-09-24

Markers for preeclampsia

#3356
20150268251
2015-09-24

BIOMARKERS IN THE SELECTION OF THERAPY OF HEART FAILURE

#3357
20150268250
2015-09-24

Method for testing for nephritis-lesion sites and reagent therefor

#3358
20150260732
2015-09-17

Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction

#3359
20150260730
2015-09-17

PROSTATITIS-ASSOCIATED ANTIGENS AND METHODS OF USE THEREOF

#3360
20150260729
2015-09-17

SCHIZOPHRENIA MARKER SET AND ITS UTILIZATION

#3361
20150260728
2015-09-17

Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation

#3362
20150260718
2015-09-17

Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm

#3363
20150259748
2015-09-17

Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease

#3364
20150259740
2015-09-17

PROCESSES AND KITS TO DETECT AND MONITOR FOR DIAGNOSTIC BIOMARKERS FOR POST TRAUMATIC STRESS DISORDER (PTSD) AND TO DIFFERENTIATE BETWEEN SUICIDAL AND NON-SUICIDAL FORM OF THE DISORDER

#3365
20150259434
2015-09-17

Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

#3366
20150259432
2015-09-17

Method of inhibiting or treating cancer metastasis

#3367
20150259412
2015-09-17

Method of treating sepsis by administering a soluble CD52 glycoprotein

#3368
20150258193
2015-09-17

Diagnostic marker for treatment of cerebral ischemia

#3369
20150258094
2015-09-17

Nanocarriers and their processing for diagnostics and therapeutics

#3370
20150257686
2015-09-17

Detecting infection in reduced pressure wound treatment

#3371
20150253340
2015-09-10

Method of cancer diagnosis, progression and response to therapy using a primary xenograft mouse model for cancer serum biomarker discovery

#3372
20150250808
2015-09-10

TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS

#3373
20150247869
2015-09-03

MARKER ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS

#3374
20150247868
2015-09-03

Methods and kits for predicting a response to an erythropoietic agent

#3375
20150247867
2015-09-03

Use of GFAP for identification of intracerebral hemorrhage

#3376
20150247847
2015-09-03

Diagnostic method for detecting an autoimmune disease

#3377
20150246113
2015-09-03

Porcine parvovirus 5A, methods of use and vaccine

#3378
20150241453
2015-08-27

Methods and compositions for detecting endometrial or ovarian cancer

#3379
20150241452
2015-08-27

Method for diagnosing muscular dystrophy

#3380
20150241451
2015-08-27

NT-proCNP as a biomarker of vascular disorders and pregnancy complication

#3381
20150241449
2015-08-27

Molecularly imprinted polymer for detection of pentraxin protein and method for preparing the same

#3382
20150241444
2015-08-27

Methods for detecting heparin/platelet factor 4 antibodies

#3383
20150239982
2015-08-27

Anti-presepsin antibody

#3384
20150233947
2015-08-20

Body Fluid BIN1 as a Marker of Cardiac Health

#3385
20150233946
2015-08-20

TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION

#3386
20150233942
2015-08-20

Use of interleukin-27 as a diagnostic biomarker for bacterial infection in critically ill patients

#3387
20150233939
2015-08-20

Methods and compositions for biomarkers of fatigue

#3388
20150232932
2015-08-20

ANKRD26 AS A MARKER FOR DIAGNOSIS OF THROMBOCYTOPENIAS

#3389
20150226751
2015-08-13

Methods for Diagnosing Mood Disorders

#3390
20150226749
2015-08-13

Method for measuring the level of circulating inhibitory factor 1 protein in a subject measuring the level of circulating inhibitory factor 1 (IF1) protein in a subject

#3391
20150226737
2015-08-13

COMPLEX COMPRSING BEAD PARTICLE INCLUDING QUANTUM DOT LAYER AND METHOD OF DIAGNOSING MYOCARDIAL INFARCTION-RELATED DISEASE BY USING THE COMPLEX

#3392
20150219675
2015-08-06

Immunoassay kit for quantification of BNP and proBNP

#3393
20150219672
2015-08-06

Biomarkers for non-alcoholic fatty liver disease, and methods for detecting non-alcoholic fatty liver disease by using such biomarkers

#3394
20150219671
2015-08-06

Method for detection of IGFBP-4 fragments

#3395
20150219670
2015-08-06

Kidney disease biomarker

#3396
20150219669
2015-08-06

Diagnostic of Heart Failure

#3397
20150219666
2015-08-06

Integrated quantification method for protein measurements in clinical proteomics

#3398
20150219664
2015-08-06

Methods and compositions for diagnosis of inflammatory liver disease

#3399
20150219659
2015-08-06

Assay

#3400
20150218544
2015-08-06

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

#3401
20150218272
2015-08-06

Compositions and methods for diagnosing and treating an inflammation

#3402
20150216929
2015-08-06

Semaphorin 3A for treatment and assessment of severity of Asthma

#3403
20150216837
2015-08-06

Treatment of circadian rhythm disorders

#3404
20150212097
2015-07-30

Monoclonal IgE antibody that binds to sweat allergy antigen protein

#3405
20150210997
2015-07-30

Methods and compounds for reducing threonyl-tRNA synthetase activity

#3406
20150210774
2015-07-30

Compositions and methods for detecting, treating and preventing diseases and disorders

#3407
20150210764
2015-07-30

Beta klotho binding proteins and methods of use thereof

#3408
20150210759
2015-07-30

Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof

#3409
20150209407
2015-07-30

METHODS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS AND BONE-RELATED DISEASES

#3410
20150205928
2015-07-23

Method for providing reliable non-invasive diagnostic tests

#3411
20150204888
2015-07-23

Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments

#3412
20150204887
2015-07-23

Human myeloid derived suppressor cell cancer markers

#3413
20150204876
2015-07-23

Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients

#3414
20150204871
2015-07-23

Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases

#3415
20150204867
2015-07-23

Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases

#3416
20150204861
2015-07-23

Use of anoctamin as a biomarker for radiation biodosimetry

#3417
20150204839
2015-07-23

Biomarkers for type 2 diabetes

#3418
20150203918
2015-07-23

Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)

#3419
20150203916
2015-07-23

PLASMA ANALYTES PREDICT DIAGNOSIS AND PROGNOSIS OF THORACIC AORTIC ANEURYSM

#3420
20150203915
2015-07-23

Screening methods for transfusion related acute lung injury (TRALI)

#3421
20150198617
2015-07-16

Blood biomarker for early blood brain barrier disruption in ischemic stroke

#3422
20150198616
2015-07-16

METHODS OF DIAGNOSING AND DETERMINING RISK OF DEVELOPING DISSEMINATED INTRAVASCULAR COAGULATION

#3423
20150198613
2015-07-16

Soluble MANF in pancreatic β-cell disorders

#3424
20150196616
2015-07-16

Angiopoietin-like 4 and a method of its use in wound healing

#3425
20150192593
2015-07-09

BIOMARKERS FOR DIAGNOSING AND/OR MONITORING TUBERCULOSIS

#3426
20150192585
2015-07-09

Detection method of mammary gland disease

#3427
20150185239
2015-07-02

Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (TIA) and peripheral arterial disease (PAD)

#3428
20150185231
2015-07-02

METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY

#3429
20150184242
2015-07-02

Susceptibility to and stratification for monoaminergic antidepressants

#3430
20150177260
2015-06-25

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS

#3431
20150177259
2015-06-25

Methods for treatment of cardiovascular disease

#3432
20150177244
2015-06-25

PARALLEL ANALYSIS OF SERUM EPCAM AND MMP7 TO DISCRIMINATE SEPSIS, NECROTIZING ENTEROCOLITIS AND NORMAL CONTROL PATIENTS

#3433
20150177146
2015-06-25

Device and associated methods for performing luminescence and fluorescence measurements of a sample

#3434
20150177145
2015-06-25

Device and associated methods for performing luminescence and fluorescence measurements of a sample

#3435
20150175695
2015-06-25

RAC1 inhibitors for the treatment of alport glomerular disease

#3436
20150175673
2015-06-25

Composition for preventing or treating fracture or osteoporosis using slit-robo system

#3437
20150173685
2015-06-25

TRIAGE SCORING SYSTEM

#3438
20150168432
2015-06-18

Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals

#3439
20150168426
2015-06-18

Methods and kits for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension

#3440
20150166631
2015-06-18

ANTI-PRO87299 ANTIBODIES

#3441
20150160241
2015-06-11

GAMMA-AMINOBUTYRIC ACID A RECEPTOR SUBUNIT BIOMARKERS

#3442
20150160240
2015-06-11

Host Biomarkers for Dengue Fever (DF) and Methods Thereof

#3443
20150160239
2015-06-11

Marker peptide for determining risk of developing metabolic syndrome, and use thereof

#3444
20150160238
2015-06-11

Means and methods for diagnosing and monitoring heart failure in a subject

#3445
20150160230
2015-06-11

Methods of predicting and decreasing the risk of pre-term birth

#3446
20150160216
2015-06-11

Methods to identify modulators of RyR calcium channels

#3447
20150153363
2015-06-04

MARKERS OF THE MALE UROGENITAL TRACT

#3448
20150153362
2015-06-04

METHODS FOR DIAGNOSING OSTEOARTHRITIS

#3449
20150153361
2015-06-04

Status of Tuberculosis Infection in an Individual

#3450
20150153360
2015-06-04

1L1RL-1 as a cardiovascular disease marker and therapeutic target

#3451
20150153331
2015-06-04

Metabolomics in pneumonia and sepsis

#3452
20150148247
2015-05-28

Methods and devices for tuberculosis diagnosis using biomarker profiles

#3453
20150147767
2015-05-28

BAG3 as biochemical serum and tissue marker

#3454
20150147758
2015-05-28

DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia

#3455
20150147281
2015-05-28

CARIES RISK TEST FOR PREDICTING AND ASSESSING THE RISK OF DISEASE

#3456
20150141510
2015-05-21

Cardiovascular disease primary prevention agent for patients having high blood levels of high-sensitivity C-reactive protein

#3457
20150141385
2015-05-21

Methods useful for vitamin D deficiency and related disorders

#3458
20150141341
2015-05-21

Methods and compositions for the treatment of β-thalassemia

#3459
20150141322
2015-05-21

Therapeutic agent, treatment method and inspection method for diseases caused by activation of neutrophils

#3460
20150140676
2015-05-21

Method for diagnosing acute alcoholic hepatitis

#3461
20150140672
2015-05-21

METHODS FOR DETECTING AMYLOID BETA AMYLOIDOSIS

#3462
20150140609
2015-05-21

Anti-αβantibodies

#3463
20150133414
2015-05-14

Compositions and methods for identifying and diagnosing salt sensitivity of blood pressure

#3464
20150133378
2015-05-14

Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin

#3465
20150132834
2015-05-14

Method for removal of triglycerides in lipoproteins other than low-density lipoproteins

#3466
20150132778
2015-05-14

METHODS AND KITS FOR DIAGNOSING HEPARIN-INDUCED THROMBOCYTOPENIA

#3467
20150132772
2015-05-14

Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal Disorders

#3468
20150132769
2015-05-14

Biomarker for determining mitochondrial damage in friedreich's ataxia

#3469
20150132318
2015-05-14

Soluble VEGFR-1 variants for diagnosis of preeclampsia

#3470
20150126623
2015-05-07

Biomarker of depression, method for measuring biomarker of depression, computer program, and recording medium

#3471
20150126622
2015-05-07

Blood biomarkers for necrotizing enterocolitis

#3472
20150126473
2015-05-07

Ultra-small ApoB-containing particles and methods of use thereof

#3473
20150126447
2015-05-07

METHOD AND KIT FOR THE CLASSIFICATION AND PROGNOSIS OF WOUNDS

#3474
20150126438
2015-05-07

Novel ChREBP Isoforms and Methods Using the Same

#3475
20150126405
2015-05-07

POLYPEPTIDE MARKERS FOR THE EARLY RECOGNITION OF THE REJECTION OF TRANSPLANTED KIDNEYS

#3476
20150126403
2015-05-07

METHOD OF IDENTIFYING PROTEINS IN HUMAN SERUM INDICATIVE OF PATHOLOGIES OF HUMAN LUNG TISSUES

#3477
20150126386
2015-05-07

Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample

#3478
20150126384
2015-05-07

Prognostic Biomarkers in Patients with Ovarian Cancer

#3479
20150125448
2015-05-07

Method for predicting the response to HER2-directed therapy

#3480
20150119275
2015-04-30

Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis

#3481
20150119271
2015-04-30

BIOMARKERS FOR THE DIAGNOSIS, PROGNOSIS, ASSESSMENT AND THERAPY STRATIFICATION OF SYNCOPE

#3482
20150118699
2015-04-30

Method of diagnosing and treating infectious disseminated intravascular coagulation

#3483
20150118698
2015-04-30

Biochemical markers for CVD risk assessment

#3484
20150118240
2015-04-30

Anti-FcRn antibodies

#3485
20150118236
2015-04-30

Method for Predicting the Risk of Getting a Cardiovascular Event in a Female Subject

#3486
20150118224
2015-04-30

ENDOTHELIAL CELLS ACTIVATION BIOMARKERS CHARACTERIZING ANTIBODY MEDIATED REJECTION AND USES THEREOF

#3487
20150118221
2015-04-30

COMPOSITIONS AND METHODS FOR TREATING CARDIAC HYPERTROPHY

#3488
20150118155
2015-04-30

Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline

#3489
20150111771
2015-04-23

Method for Identifying Agents Capable of Inducing Respiratory Sensitization and Array and Analytical Kits for Use in the Method

#3490
20150111770
2015-04-23

Quantitative determination of biomarkers in the erythrocyte membrane

#3491
20150111224
2015-04-23

BIOMARKERS FOR ADVERSE CARDIAC REMODELING

#3492
20150105293
2015-04-16

CLINICAL DIAGNOSIS OF HEPATIC FIBROSIS USING A NOVEL PANEL OF LOW ABUNDANT HUMAN PLASMA PROTEIN BIOMARKERS

#3493
20150105291
2015-04-16

Method for evaluating ischemic heart disease by assaying complement factor H or D

#3494
20150105278
2015-04-16

METHODS OR RISK ASSESSMENT OF PML AND RELATED APPARATUS

#3495
20150104881
2015-04-16

SGLT2 AS BIOMARKER FOR DIAGNOSING CHRONIC KIDNEY DISEASE AND MONITORING THE DISEASE STATUS AFTER TREATMENT

#3496
20150104809
2015-04-16

Detection and treatment of cancer

#3497
20150099704
2015-04-09

Peptide inhibitors of calcium oxalate monohydrate crystallization and uses thereof

#3498
20150099664
2015-04-09

PGLYRP2 biomarker in idiopathic pneumonia syndrome

#3499
20150099658
2015-04-09

Anti-GP41 antibody-specific capture agents, compositions, and methods of using and making

#3500
20150094268
2015-04-02

Prophylactic or therapeutic agent for hepatic diseases

#3501
20150094230
2015-04-02

Method and system for detecting and differentiating cancer and sepsis in mammals using biomarkers

#3502
20150093763
2015-04-02

Method for diagnosis of pulmonary involvement in systemic sclerosis

#3503
20150093448
2015-04-02

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

#3504
20150087527
2015-03-26

METHOD AND KIT FOR THE CLASSIFICATION AND PROGNOSIS OF TISSUE OR ORGAN FIBROSIS IN A REPARATIVE OR REACTIVE PROCESS

#3505
20150086986
2015-03-26

METHOD TO PREDICT THE PRESENCE OF INFLAMMATION OR ITACONIC ACID, IRG1 AND/OR PROTEIN IRG1 IN A SUBJECT AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLAMMATION

#3506
20150086572
2015-03-26

Complement Pathway Inhibitors Binding To C5 And C5A Without Preventing The Formation Of C5B

#3507
20150086568
2015-03-26

Anti-VEGF antibodies

#3508
20150081224
2015-03-19

Predicting risk of major adverse cardiac events

#3509
20150080452
2015-03-19

Compositions and methods related to protein displacement therapy for myotonic distrophy

#3510
20150080236
2015-03-19

METHOD OF SUB-CLASSIFYING BREAST CANCER TUMORS

#3511
20150079696
2015-03-19

Prognosis of adverse events in patients with suspected chronic heart failure

#3512
20150079615
2015-03-19

Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure

#3513
20150079120
2015-03-19

DNA sequence and preparation of grass pollen allergen Phl p 4 by recombinant methods

#3514
20150079116
2015-03-19

Diagnostic tools for response to 6-thiopurine therapy

#3515
20150079111
2015-03-19

MECHANISM, DIAGNOSTIC, AND TREATMENTS FOR COMPLICATIONS OF RENAL FAILURE

#3516
20150079097
2015-03-19

S100A4 antibodies and therapeutic uses thereof

#3517
20150079055
2015-03-19

Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease

#3518
20150072881
2015-03-12

Methods to Assess Treatment Outcomes in Reward Deficiency Syndrome (RDS) Behaviors Utilizing Expression Profiling

#3519
20150072363
2015-03-12

Phenylacetylglutamine as a biomarker for healthy aging

#3520
20150072356
2015-03-12

Use of integrin beta subunits in the diagnosis of venous thromboembolism

#3521
20150072320
2015-03-12

PC-O 40:1 as a biomarker for healthy aging

#3522
20150072043
2015-03-12

9-oxo-HODE as a biomarker for healthy aging

#3523
20150072022
2015-03-12

Fractional C-reactive protein (fracCRP) antibodies and assays

#3524
20150071934
2015-03-12

Methods For Regulating Hair Growth Disorders

#3525
20150065556
2015-03-05

THERAPEUTIC TARGETS FOR MITOCHONDRIAL DISORDERS

#3526
20150065460
2015-03-05

Method of assessing pancreatic beta-cell function

#3527
20150065455
2015-03-05

METHODS OF ASSESSING SUSCEPTIBILITY TO DRUG-INDUCED THROMBOCYTOPENIA

#3528
20150065391
2015-03-05

POLYPEPTIDE MARKERS FOR DIAGNOSIS AND ASSESSMENT OF HEART FAILURE

#3529
20150065374
2015-03-05

Detection of platelet-derived shed CD31

#3530
20150065372
2015-03-05

Device and method for detection of analytes

#3531
20150065365
2015-03-05

Thermoelectric sensor for analytes in a gas and related method

#3532
20150064728
2015-03-05

Process for determining the susceptibility to nosocomial infections

#3533
20150064211
2015-03-05

Synthetic active peptide fragments

#3534
20150057343
2015-02-26

Method and composition for treating acne

#3535
20150057325
2015-02-26

COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST

#3536
20150056641
2015-02-26

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

#3537
20150056640
2015-02-26

Reagents and methods for detecting a polymorphic protein

#3538
20150056203
2015-02-26

Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject

#3539
20150051259
2015-02-19

Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary disease

#3540
20150050303
2015-02-19

Compositions for treatment of celiac disease

#3541
20150050293
2015-02-19

Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome

#3542
20150045334
2015-02-12

Diagnostic methods of eosinophilic esophagitis

#3543
20150045255
2015-02-12

Endometrial phase or endometrial cancer biomarkers

#3544
20150045245
2015-02-12

BIOMARKERS AND TEST PANELS USEFUL IN SYSTEMIC INFLAMMATORY CONDITIONS

#3545
20150044722
2015-02-12

Nucleic acids encoding anti-Siglec-15 antibodies

#3546
20150044706
2015-02-12

Methods for diagnosis and prognosis of renal injury and renal failure

#3547
20150038595
2015-02-05

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

#3548
20150038530
2015-02-05

Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage

#3549
20150038496
2015-02-05

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES

#3550
20150038350
2015-02-05

Analytical tool and method for determining a condition of an oral cavity

#3551
20150037819
2015-02-05

Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulin

#3552
20150037789
2015-02-05

Systemic genotoxicity as blood marker for allergic inflammation

#3553
20150037421
2015-02-05

ARRDC1-mediated microvesicles (ARMMs) and uses thereof

#3554
20150037353
2015-02-05

METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2

#3555
20150037325
2015-02-05

ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2

#3556
20150031616
2015-01-29

Use of relaxin to treat placental syndromes

#3557
20150031057
2015-01-29

METHOD FOR THE DETERMINATION OF RENAL FUNCTION

#3558
20150031053
2015-01-29

ASSAY AND METHOD FOR DETERMINING INSULIN-RESISTANCE

#3559
20150031049
2015-01-29

Method of predicting acute appendicitis

#3560
20150025008
2015-01-22

Compositions and Methods of Detecting and Treating Neural Tube Defects

#3561
20150025004
2015-01-22

KIDNEY FUNCTION BIOMARKERS

#3562
20150024422
2015-01-22

Method of determination of risk of 2 hour blood glucose equal to or greater than 140 mg/dL

#3563
20150023879
2015-01-22

Diagnostic chewing gum for pathogens

#3564
20150018246
2015-01-15

POLYPEPTIDE MARKER FOR DIAGNOSING AND ASSESSING VASCULAR DISEASES

#3565
20150018237
2015-01-15

MEANS AND METHODS FOR ASSESSING BONE DISORDERS

#3566
20150018234
2015-01-15

Biomarkers for diagnosing ischemia

#3567
20150017738
2015-01-15

Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress

#3568
20150017667
2015-01-15

MEANS AND METHODS FOR ASSESSING LIVER DISORDERS

#3569
20150017232
2015-01-15

Oligopeptidic compounds and uses thereof

#3570
20150017200
2015-01-15

Fusion proteins and their use in the diagnosis and treatment of leishmaniasis

#3571
20150017119
2015-01-15

Methods for diagnosis, prognosis and methods of treatment

#3572
20150017101
2015-01-15

Device for the diagnosis of inflammatory tissues in dental applications

#3573
20150017099
2015-01-15

Diagnosis and treatment for respiratory tract diseases

#3574
20150011423
2015-01-08

MEANS AND METHODS FOR ASSESSING KIDNEY TOXICITY

#3575
20150011412
2015-01-08

System for detecting infection in synovial fluid

#3576
20150011017
2015-01-08

Diagnosis and risk stratification by determining the marker CT-proADM

#3577
20150010929
2015-01-08

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

#3578
20150010928
2015-01-08

MEANS AND METHODS FOR ASSESSING AN ENDOCRINE DISEASE OR DISORDER

#3579
20150010673
2015-01-08

P-cresol sulphate as a biomarker for healthy aging

#3580
20150010631
2015-01-08

Immune-modifying nanoparticles for the treatment of inflammatory diseases

#3581
20150005526
2015-01-01

Catalyst and process for preparing acrolein and/or acrylic acid by dehydration reaction of glycerin

#3582
20150005367
2015-01-01

ADAM12 inhibitors and their use against inflammation-induced fibrosis

#3583
20150005260
2015-01-01

METHODS FOR THE DETECTION AND THE TREATMENT OF DIASTOLIC DYSFUNCTION

#3584
20150005237
2015-01-01

PEPTIDIC INHIBITOR OF SIGNAL TRANSMISSION FROM G-ALPHA-S TO G-ALPHA-I-COUPLED RECEPTOR CASCADES

#3585
20150005195
2015-01-01

Biomarkers for insulin resistance and methods using the same

#3586
20150005192
2015-01-01

BIOMARKERS

#3587
20150005183
2015-01-01

PROTEIN BIOMARKERS OF LATE STAGE BREAST CANCER

#3588
20150005182
2015-01-01

PROTEIN BIOMARKERS OF RECURRENT BREAST CANCER

#3589
20150004622
2015-01-01

Biomarker for Barrett's Oesophagus

#3590
20150004621
2015-01-01

BIOLOGICAL MARKER FOR EARLY CANCER DETECTION AND METHODS FOR CANCER DETECTION (BF819)

#3591
20150004608
2015-01-01

MONOCYTE-DERIVED NUCLEIC ACIDS AND RELATED COMPOSITIONS AND METHODS

#3592
20140378445
2014-12-25

Methods for treating vascular leak syndrome

#3593
20140378347
2014-12-25

Multiplexed assay kit to evaluate the efficacy of treatment for inflammatory bowel disease

#3594
20140378332
2014-12-25

Health test for a broad spectrum of health problems

#3595
20140377786
2014-12-25

DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL

#3596
20140377777
2014-12-25

Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2

#3597
20140377769
2014-12-25

LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES

#3598
20140371111
2014-12-18

System and method for determining individualized medical intervention for a disease state

#3599
20140371103
2014-12-18

METHODS AND REAGENTS FOR EVALUATING AUTOIMMUNE DISEASE AND DETERMINING ANTIBODY REPERTOIRE

#3600
20140371089
2014-12-18

METHOD FOR DIGANOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36